IRIDEX
Civil EngineeringRomania11-50 Employees
Geosynthetics
Innovative Laser Technology Iridex specializes in versatile laser-based medical systems for glaucoma and retinal disease treatment, presenting opportunities to collaborate with clinics seeking advanced ophthalmic laser solutions.
Expanding Market Presence The company's plans to relocate its headquarters from Mountain View to San Jose indicate a strategic move to strengthen its market footprint in California, potentially increasing visibility and sales within Silicon Valley healthcare networks.
Clinical Evidence & Research Published studies demonstrating the safety and effectiveness of MicroPulse technology suggest a growing confidence in Iridex's products, creating sales opportunities by targeting ophthalmology clinics looking for validated treatment options.
Financial Growth Signals Recent operational and financial results, along with global sales momentum, suggest a positive trajectory, making Iridex a promising candidate for partnerships and resellers aiming to expand their ophthalmic technology portfolio.
Industry Recognition Coverage from industry analysts and participation in investor conferences indicate increased visibility and interest, offering sales teams a platform to connect with stakeholders interested in cutting-edge ophthalmic medical devices.
| IRIDEX Email Formats | Percentage |
| FLast@iridex.com | 77% |
| Last@iridex.com | 13% |
| FirstLast@iridex.com | 5% |
| First.Last@iridex.com | 3% |
| FMiddleLast@iridex.com | 1% |
| First@iridex.com | 1% |
| First.Last@iridexgroup.ro | 100% |
IRIDEX's revenue is estimated to be in the range of $1M
IRIDEX's revenue is estimated to be in the range of $1M